Furthermore, aberrant expression of the p53 protein was correlated with hemizygous TP53 deletion in lymphoproliferative diseases such as CLL (p < 0.001) and multiple myeloma (MM) (p < 0.001) [79,80,81]. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.